These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1666760)

  • 1. Positron emission tomography of brain dopamine D-1 receptors with 11C-SCH 23390 in Parkinson's disease.
    Rinne JO; Laihinen A; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():152. PubMed ID: 1666760
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.
    Laihinen A; Rinne JO; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():151. PubMed ID: 1666759
    [No Abstract]   [Full Text] [Related]  

  • 3. PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.
    Laihinen AO; Rinne JO; Ruottinen HM; Någren KA; Lehikoinen PK; Oikonen VJ; Ruotsalainen UH; Rinne UK
    J Nucl Med; 1994 Dec; 35(12):1916-20. PubMed ID: 7989969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease.
    Rinne JO; Laihinen A; Någren K; Bergman J; Solin O; Haaparanta M; Ruotsalainen U; Rinne UK
    J Neurosci Res; 1990 Dec; 27(4):494-9. PubMed ID: 1981915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical and neuroreceptor imaging with PET in Parkinson's disease.
    Stoessl AJ
    Adv Neurol; 2001; 86():215-23. PubMed ID: 11553980
    [No Abstract]   [Full Text] [Related]  

  • 6. [Positron emission tomography studies of dopamine D1 receptors].
    Shinotoh H
    Nihon Rinsho; 1991 Jul; 49(7):1541-5. PubMed ID: 1832196
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron tomography of a radio-brominated analog of the D1/DA1 antagonist, SCH 23390.
    Friedman AM; DeJesus OT; Woolverton WL; van Moffaert G; Goldberg LI; Prasad A; Barnett A; Dinerstein RJ
    Eur J Pharmacol; 1985 Feb; 108(3):327-8. PubMed ID: 3886409
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of positron-emitting SCH 23390 analogs as tracers for CNS dopamine D1 receptors.
    DeJesus OT; Van Moffaert GJ; Friedman AM
    Int J Rad Appl Instrum B; 1989; 16(1):47-50. PubMed ID: 2654085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in psychiatric brain imaging.
    Sedvall G; Farde L; Nybäck H; Pauli S; Persson A; Savic I; Wiesel FA
    Acta Radiol Suppl; 1990; 374():113-5. PubMed ID: 1966956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging of dopamine D1 and D2 receptors by a high resolution positron emission tomography.
    Shinotoh H; Aotsuka A; Inoue O; Suzuki K; Fukuda H; Iyo M; Yamazaki T; Tateno Y; Hirayama K; Nohara N
    Adv Exp Med Biol; 1991; 287():249-53. PubMed ID: 1836930
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine D1 and D2 receptors in Parkinson's disease and striatonigral degeneration determined by PET.
    Shinotoh H; Hirayama K; Tateno Y
    Adv Neurol; 1993; 60():488-93. PubMed ID: 8420176
    [No Abstract]   [Full Text] [Related]  

  • 12. Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease.
    Hägglund J; Aquilonius SM; Bergström K; Eckernäs SA; Hartvig P; Lundqvist H; Långström B; Malmborg P; Någren K
    Adv Neurol; 1987; 45():99-101. PubMed ID: 2950732
    [No Abstract]   [Full Text] [Related]  

  • 13. Atlas of dopamine receptor images (PET) of the human brain.
    Inoue Y; Wagner HN; Wong DF; Links JM; Frost JJ; Dannals RF; Rosenbaum AE; Takeda K; Di Chiro G; Kuhar MJ
    J Comput Assist Tomogr; 1985; 9(1):129-40. PubMed ID: 3155755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11C-WIN 35,428 for detecting dopamine depletion in mild Parkinson's disease.
    Madras BK
    Ann Neurol; 1994 Mar; 35(3):376-7. PubMed ID: 8122895
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography.
    Halldin C; Stone-Elander S; Farde L; Ehrin E; Fasth KJ; Långström B; Sedvall G
    Int J Rad Appl Instrum A; 1986; 37(10):1039-43. PubMed ID: 3027000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of [11C]SCH 23390 for dopamine D1 receptor studies.
    DeJesus OT; Van Moffaert GJ; Friedman AM
    Int J Rad Appl Instrum A; 1987; 38(5):345-8. PubMed ID: 3038787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease.
    Pimoule C; Schoemaker H; Reynolds GP; Langer SZ
    Eur J Pharmacol; 1985 Aug; 114(2):235-7. PubMed ID: 2864273
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine receptors in Parkinson's disease.
    Guttman M
    Neurol Clin; 1992 May; 10(2):377-86. PubMed ID: 1584180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET study on striatal dopamine D2 receptor changes during the progression of early Parkinson's disease.
    Rinne JO; Laihinen A; Rinne UK; Någren K; Bergman J; Ruotsalainen U
    Mov Disord; 1993 Apr; 8(2):134-8. PubMed ID: 8474478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.